Concepedia

Jonathan Rubino

JR

3

Publications

101

Citations

3

H-Index

2021

Active since

Affiliations

Institut Curie(Current)

Centre de recherche en Epidémiologie et Santé des Populations

Centre de Recherche en Cancérologie de Marseille

Hôpital de la Timone

Université Paris Sciences et Lettres

Jonathan Rubino is an author at Institut Curie specializing in cancer therapeutics, cancer research, and medicine.

ORCID

Top concepts

Publications per year

2021–2023

3

Publications

3

Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium

Claudia Pasqualini, Jonathan Rubino, Caroline Brard et al. · European Journal of Cancer · 2021 · 52 citations · Full text

, , +11

First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial

Raphael J. Morscher, Caroline Brard, Pablo Berlanga et al. · European Journal of Cancer · 2021 · 36 citations · Full text

, , +10

Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial

Susanne A. Gatz, Anne C. Harttrampf, Caroline Brard et al. · Clinical Cancer Research · 2023 · 13 citations

Rows per page

1–3 of 3